World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs ; volume:6 ; number:1 ; day:6 ; month:9 ; year:2007 ; pages:1-9 ; date:12.2007
Malaria journal ; 6, Heft 1 (6.9.2007), 1-9, 12.2007
- Urheber
-
Price, Ric N.
- Beteiligte Personen und Organisationen
-
Dorsey, Grant
Ashley, Elizabeth A.
Barnes, Karen I.
Baird, J Kevin
D'Alessandro, Umberto
Guerin, Philippe J.
Laufer, Miriam K.
Naidoo, Inbarani
Nosten, François
Olliaro, Piero
Plowe, Christopher V.
Ringwald, Pascal
Sibley, Carol H.
Stepniewska, Kasia
White, Nicholas J.
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-6-119
- URN
-
urn:nbn:de:1111-201608064794
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Price, Ric N.
- Dorsey, Grant
- Ashley, Elizabeth A.
- Barnes, Karen I.
- Baird, J Kevin
- D'Alessandro, Umberto
- Guerin, Philippe J.
- Laufer, Miriam K.
- Naidoo, Inbarani
- Nosten, François
- Olliaro, Piero
- Plowe, Christopher V.
- Ringwald, Pascal
- Sibley, Carol H.
- Stepniewska, Kasia
- White, Nicholas J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
How antimalarial drug resistance affects post-treatment prophylaxis
The threat of antimalarial drug resistance
The role of anti-malarial drugs in eliminating malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
The consequences of artemisinin resistance in falciparum malaria
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
How antimalarial drug resistance affects post-treatment prophylaxis
The threat of antimalarial drug resistance
The role of anti-malarial drugs in eliminating malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
The consequences of artemisinin resistance in falciparum malaria
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology
Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
How antimalarial drug resistance affects post-treatment prophylaxis
The threat of antimalarial drug resistance
The role of anti-malarial drugs in eliminating malaria
Anti‐malarial drug effects on parasite dynamics in vivax malaria
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria
Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
The consequences of artemisinin resistance in falciparum malaria
Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology